Smart Medicine

PCOS to PMOS: What the Name Change Means for Women’s Health

Smart Medicine

Show Notes

For ninety years, the name we gave one of the most common conditions in women's health pointed everyone in the wrong direction.

In this episode of Smart Medicine, Dr. Scott Sigman sits down with Dr. Melanie Cree, a pediatric endocrinologist, who helped lead the international effort to rename polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). Dr. Cree explains the condition at its core, why the old framing left most patients undiagnosed, and shares early data on GLP-1s that points to a new path forward. She also has a direct message for frontline clinicians that not only impacts the women affected by this condition but the healthcare system at large.

If you want to understand where women's health is headed, start here.

More from Smart Medicine

Oct 21, 2026

Are you ready for the next wave of AI in healthcare?

Oct 7, 2026

What if the real promise of AI in medicine isn't to replace the human touch, but to give it back?

Sep 23, 2026

The role of the physician is changing, and the time to react is now.

Sep 9, 2026

Ask any surgeon what's wrong with the hospital system, and you'll get an earful. Ask what to do about it, and the room gets quiet. Well, except in this episode.

Aug 12, 2026

Peptides are flooding social media, locker rooms, and doctors' offices, but is the research actually keeping pace?

See all episodes →